ACIP recommends additional updated COVID-19 vaccine dose for adults 65 and older
Should older adults get another COVID-19 shot? Health advisors say yes.
The Advisory Committee on Immunization Practices (ACIP) has issued a recommendation for all adults aged 65 years and older in the United Sta…
National health experts now recommend that everyone age 65 and older get an extra updated COVID-19 vaccine shot to stay protected.
COVID-19 survivors show brain network alterations in default mode and limbic systems
Does COVID-19 change how your brain is wired? A new map suggests it might.
A systematic review and meta-analysis of 703 COVID-19 survivors and 596 healthy controls across 19 neuroimaging studies found structural and…
A new brain map shows COVID-19 survivors often have changes in the same networks used for daydreaming and emotions.
COVID-19 pandemic altered timing of psychiatric admissions across three European countries
COVID-19 pandemic changed timing of psychiatric hospital admissions in three European countries
A retrospective multicenter observational study of psychiatric hospitalizations in Austria, Germany, and Italy (2017-2020) found the pandemi…
COVID-19 did not increase psychiatric hospitalizations but shifted when patients in Austria, Germany, and Italy were admitted to hospitals.
Sentinel surveillance and sequencing used to characterize SARS-CoV-2 community transmission in New York City
How did COVID-19 spread through New York City communities?
A surveillance report from New York City used sentinel monitoring of influenza-like symptoms and genetic sequencing to characterize communit…
New York City health officials used genetic sequencing to track how the virus spread through neighborhoods and identify infection origins.
Psychiatric facility's COVID-19 prevention response described after admitting two infected patients
Psychiatric hospital describes COVID-19 prevention measures after admitting infected patients
A case report describes the response at a psychiatric hospital in Wyoming after admitting two patients with COVID-19. No specific outcomes o…
A Wyoming psychiatric hospital admitted two COVID-19 patients and shared the steps it took to stop the virus from spreading to others.
COVID-19 associated with increased lung cancer risk in current smokers; spike protein drives tumorigenesis in mice
Study finds link between COVID-19 and higher lung cancer risk in current smokers
A retrospective cohort analysis of 166,807 current smokers found COVID-19 was associated with increased lung cancer risk (RR 1.22; HR 1.50).…
Current smokers with a history of COVID-19 face a higher risk of developing lung cancer, a link scientists traced to a specific virus protei…
COVID-19 was the third leading cause of death in the United States in 2021
COVID-19 was the third leading cause of death in the United States in 2021
A 2021 U.S. mortality data report indicates COVID-19 was the third leading cause of death, following heart disease and cancer. This observat…
In 2021, COVID-19 remained the third leading cause of death in the United States, trailing only heart disease and cancer.
Report describes COVID-19 deaths among US cancer survivors in 2021
How many cancer survivors died with COVID-19 listed as a cause in 2021?
A descriptive report examined deaths among cancer survivors in the United States during 2021 where COVID-19 was listed as an underlying caus…
A 2021 report confirms COVID-19 was a documented cause of death for some cancer survivors, though it lacks specific numbers or comparisons t…
Simulation study finds HEPA air cleaners and masking reduce exposure to simulated SARS-CoV-2 aerosols.
Can air cleaners and masks reduce COVID risk indoors? A lab test suggests yes.
A simulation study in a meeting room setting found that using HEPA air cleaners and masking reduced exposure to simulated SARS-CoV-2 aerosol…
Using portable air cleaners and masks together reduced simulated virus particles in a mock meeting room, suggesting these common tools can w…
Case report: Ravulizumab successfully treated COVID-19-triggered complement-mediated TMA in a kidney transplant recipient
Doctors report a single case where ravulizumab treated a rare blood disorder after COVID-19 in a kidney transplant patient.
A case report describes a 75-year-old kidney transplant recipient who developed complement-mediated thrombotic microangiopathy (CM-TMA) trig…
A kidney transplant patient with COVID-19 improved after doctors treated a rare blood disorder with ravulizumab, showing age shouldn't block…
Phase 1/2/3 trial of BNT162b2, BNT162b1, and BNT162b2SA COVID-19 vaccines in 46,969 healthy individuals
How did the original COVID-19 vaccine hold up? A massive study tested its safety and effectiveness in nearly 47,000 people.
This Phase 1/2/3, randomized, placebo-controlled, observer-blind study evaluated the safety, tolerability, immunogenicity, and efficacy of t…
A massive study tested the safety and effectiveness of the original COVID-19 vaccine in nearly 47,000 healthy people across different ages.